Table 3.
Outcomes for individual patients after local therapy
| Patient | Intervention | Time to Progression (months) |
Time to treatment change (months) |
Time to death (months) |
|---|---|---|---|---|
| 1 | Lung-lobectomy | 1+* | 1+ | 1+ |
| 2 | Lung-SRS** | 2+ | 2+ | 2+ |
| 3 | Adrenalectomy | 4+ | 4+ | 4+ |
| 4 | Lymph node (mediastinal and supraclavicular)-RT** | 3 | 4 | 5+ |
| 5 | Lung-pneumonectomy | 2 | 8 | 8 |
| 6 | Lung-RFA | 2 | 3 | 18 |
| 7 | Lung-RFA | 4 | 22+ | 22+ |
| 8 | Lung-lobectomy | 25+ | 25+ | 25+ |
| 9 | Lung-RT** | 9 | 9 | 26 |
| 10 | Lung-lobectomy | 15 | 16 | 26 |
| 11 | Adrenalectomy | 1 | 4 | 28 |
| 12 | Lung-pneumonectomy | 21 | 21 | 29 |
| 13 | Lung-pneumonectomy | 28 | 29 | 32+ |
| 14 | Lung-wedge | 2 | 6 | 42 |
| 15 | Lung-lobectomy | 12 | 30 | 43+ |
| 16 | Lung-lobectomy | 45+ | 45+ | 45+ |
| 17 | Lung-lobectomy | 51 | 54 | 64 |
| 18 | Lung-lobectomy | 10 | 23 | 65+ |
*
+ indicates patients who have not died or progressed during study follow up
**
Lung SRS was 4500cGy/5 fractions, Lung RT was 6000cGy/3 fractions and Lymph node RT was 5000cGy/25 fractions